加载中
NASDAQHealthcareMedical - Diagnostics & Research
最新数据
US$1.12
+US$0.02 · +1.82%
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
常规交易时段
US$1.12
+US$0.02 · +1.82%
盘中时间采用ET。市场数据可能有所延迟。
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
日内区间
当前US$1.12
52周区间
当前US$1.12
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
16
估值过高
情绪
52
多空交织
风险
74
高风险
动量
17
强势下行
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
日内区间
当前US$1.12
52周区间
当前US$1.12
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 192.9万 USD | 929.11万 USD | 992.82万 USD | 1040.23万 USD | 1113.53万 USD |
| 销货成本 | 190.49万 USD | 530.27万 USD | 482.03万 USD | 475.7万 USD | 524.9万 USD |
| 毛利 | 2.41万 USD | 398.84万 USD | 510.79万 USD | 564.53万 USD | 588.63万 USD |
| 研究与开发 | 215.98万 USD | 353.03万 USD | 356.69万 USD | 265.63万 USD | 183.79万 USD |
| 销售、一般及管理费用 | 659.52万 USD | 1264.83万 USD | 1167.99万 USD | 1237.4万 USD | 939.97万 USD |
| 营业费用 | 900.2万 USD | 1671.64万 USD | 1627.73万 USD | 1583.14万 USD | 1181.15万 USD |
| 利息收入 | 3748 USD | 4.41万 USD | 33.98万 USD | 16.93万 USD | 1.14万 USD |
| 利息支出 | 1949 USD | 22.01万 USD | 23.08万 USD | 23.9万 USD | 210.27万 USD |
| 折旧和摊销 | 173.09万 USD | 229.42万 USD | 211.51万 USD | 120.52万 USD | 100.4万 USD |
| 营业利润 | −897.79万 USD | −1272.8万 USD | −1116.93万 USD | −1018.61万 USD | −592.52万 USD |
| 净利润 | −1048.75万 USD | −1249.78万 USD | −1109.95万 USD | −1024.59万 USD | −896.18万 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2026年4月28日 | 1:40 | — | — |
股票拆分 | 2024年9月16日 | 1:20 | — | — |
已生效 2026年4月28日
1:40
已生效 2024年9月16日
1:20
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
